Products with Inhibitors bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3705 | Inulanolide A |
| 1. Inulanolide A has potent cytotoxicity. 2. Inulanolide A is a novel NFAT1 and MDM2 dual targeting agent and may be a clinical candidate for breast cancer therapy. | |
| BCN3707 | Delta3,2-Hydroxylbakuchiol |
| 1. Delta3,2-Hydroxylbakuchiol acts by protecting dopaminergic neurons from MPP(+) injury and preventing against MPTP-induced behavioral and histological lesions in the Parkinson's disease (PD) model, possibly by inhibiting monoamine transporters. 2. Delta3,2-Hydroxylbakuchiol, a monoamine transporter inhibitor involved in regulating dopaminergic and noradrenergic neurotransmission and may have represented potential pharmacotherapies for disorders such as Parkinson's disease, depression, and cocaine addiction. | |
| BCN3720 | Gama-Tocotrienol |
| 1. Gamma-Tocotrienol has antioxidant activity, it as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. 2. Gamma-Tocotrienol can induce the apoptosis on human gastric cancer SGC-7901 cells via mitochondria-dependent apoptosis pathway, it may as a potential, new chemopreventive agent for human gastric cancer. 3. Gamma-Tocotrienol is a novel blocker of the STAT3 activation pathway, with a potential role in future therapies for HCC and other cancers. | |
| BCN3729 | Cis-N-Feruloyltyramine |
| 1. Cis-N-Feruloyltyramine shows cytotoxicity against the P-388 cancer cell line. 2. N-cis-Feruloyltyramine and N-trans-Feruloyltyramine are the inhibitors of in vitro prostaglandin (PG) synthesis. | |
| BCN3739 | Peroxydehydrotumulosic acid |
| 1. 5alpha,8alpha-Peroxydehydrotumulosic acid exhibits inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. | |
